HomeNews UpdatesMarketsandMarkets Cited as a Major Reference by Biocartis for Companion Diagnostics Market

Biocartis | January 15, 2018
MarketsandMarkets Cited as a Major Reference by Biocartis for Companion Diagnostics Market

Marketsandmarkets was recently recognized as a key source by Biocartis in their corporate presentation for major insights on the global companion diagnostics market.

Companion diagnostic is done with the help of in-vitro diagnostic device (IVD) for identifying whether a particular drug through the biomarker assessment would be beneficial for a patient with certain diseases. The global market for companion diagnostics is projected to reach a value of USD 6.51 Billion by 2022, growing at a CAGR of 20.1% between 2017 and 2022, owing to the improvements in regulatory guidelines, rising need for targeted therapies, increasing cases of cancer across the globe, and increased collaborations and partnerships for companion diagnostics test development.

For More Details:


Report mentioned in the above news is,

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022

Press Release:


Other Related Report

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

Press Release:


Share this story

How can we help you?

To discuss how our team can help you and your business achieve true results,
Get in touch with us

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved